- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02350660
Oral Immunotherapy for Peanut and Mammalian Meat Allergies
November 2, 2020 updated by: Scott Commins, MD, University of Virginia
Pilot study to assess the effect of oral immunotherapy on specific Immunoglobulin E (IgE) levels and antigen consumption in two distinct food allergies.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
In subjects with mammalian meat allergy, the effect of daily oral cow's milk on immune parameters and desensitization will be assessed.
Similarly, in subjects with a peanut allergy the effects of low dose peanut flour will be assessed and comparisons between two distinct food allergies.
Study Type
Interventional
Enrollment (Actual)
24
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Virginia
-
Charlottesville, Virginia, United States, 22908
- University of Virginia
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
4 years to 80 years (ADULT, OLDER_ADULT, CHILD)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Presence or absence of specific IgE to alpha-gal or peanut
Exclusion Criteria:
- History of severe anaphylaxis
- allergy to cow's milk protein
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: TREATMENT
- Allocation: NON_RANDOMIZED
- Interventional Model: PARALLEL
- Masking: NONE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
EXPERIMENTAL: Cow's milk for alpha-gal allergics
daily consumption of cow's milk
|
daily consumption of cow's milk
|
EXPERIMENTAL: Peanut powder
peanut oral immunotherapy
|
peanut oral immunotherapy
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
The Level of Allergen Consumed Post-oral Immunotherapy
Time Frame: Following 36 months of maintenance oral immunotherapy, participants completed an open challenge at month 37
|
consumption of cow's milk or peanut flour at open challenge.
This is a single time-point assessment; not measured repeatedly.
|
Following 36 months of maintenance oral immunotherapy, participants completed an open challenge at month 37
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Scott Commins, MD, University of Virginia
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
March 1, 2012
Primary Completion (ACTUAL)
September 1, 2014
Study Completion (ACTUAL)
June 1, 2015
Study Registration Dates
First Submitted
January 21, 2015
First Submitted That Met QC Criteria
January 27, 2015
First Posted (ESTIMATE)
January 30, 2015
Study Record Updates
Last Update Posted (ACTUAL)
November 3, 2020
Last Update Submitted That Met QC Criteria
November 2, 2020
Last Verified
November 1, 2020
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 15098
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Food Hypersensitivity
-
University of Missouri-ColumbiaTerminated
-
University Hospital, AngersUnknown
-
University of ZurichRecruitingHypersensitivity, FoodSwitzerland
-
Prollergy dba Ready Set FoodObvioHealthNot yet recruitingFood Allergy in Infants
-
Ruijin HospitalRecruiting
-
Assistance Publique - Hôpitaux de ParisRecruiting
-
Vilnius UniversityEnrolling by invitationFood Allergy in Children | Food Allergy in InfantsLithuania
-
Ann & Robert H Lurie Children's Hospital of ChicagoNational Institute of Allergy and Infectious Diseases (NIAID)Enrolling by invitationFood Allergy Peanut | Food Allergy in InfantsUnited States
-
Assistance Publique Hopitaux De MarseilleUnknown
-
National Taiwan University HospitalUnknown
Clinical Trials on cow's milk
-
Danone Asia Pacific Holdings Pte, Ltd.Completed
-
General University Hospital of ValenciaCompleted
-
Auburn UniversityNot yet recruiting
-
Mead Johnson NutritionFederal University of BahiaCompletedChild Nutrition SciencesBrazil
-
Imperial College LondonJP Moulton Charitable Foundation; Sociedad Española de Alergología e Inmunología and other collaboratorsCompletedFood AllergySpain, United Kingdom
-
Meir Medical CenterSchneider Children's HospitalRecruitingCow Milk Allergy | NewbornsIsrael
-
Mead Johnson NutritionWithdrawnGrowthUnited States
-
Société des Produits Nestlé (SPN)CompletedToddlers Bone MetabolismPhilippines
-
Mount Sinai Hospital, CanadaMitacsRecruitingGestational Diabetes | Small for Gestational Age at Delivery | type1diabetes | Type2diabetesCanada
-
Wolfson Medical CenterCompletedCan Milk Allergic Patients Tolerate Baked Milk ProductsIsrael